US Edition
Decades of Studies Link Suicide Risk With Common Hair Loss Treatment
Research from Israel shows finasteride users face significant risks of mood disorders and suicide, with experts urging regulatory reassessment and improved post-approval safety studies.
- Last month, a new Israeli study published in The Journal of Clinical Psychiatry found patients using finasteride face higher risks of mood disorders and suicidal thoughts.
- Regulatory records show patient reports of Post‑Finasteride Syndrome surfaced in the early 2000s, while internal FDA experts allegedly advised suicide warnings rejected until decades later despite 18 suicides recorded by 2011.
- Clinical reports add that animal studies show brain inflammation and hippocampus changes, persistent patient symptoms include insomnia and suicidal thoughts, and independent analyses highlight increased psychiatric outcomes.
- Professor Mayer Brezis is calling to suspend finasteride marketing for cosmetic use until independent safety reviews are completed, while Organon defends product safety and urges patients and healthcare providers to discuss concerns as regulators continue reviewing data.
- Given androgenetic alopecia affects about 80 million Americans, experts call for enforced post‑approval analytical studies and testing of stevioside‑minoxidil microneedle patches as safer alternatives.
9 Articles
9 Articles
New research in Israel suggests that patients who use a popular male baldness medication are at increased risk of mood disorders and suicidal thoughts compared to those who do not use it. Read more]]>
Sci Tech Daily
UpstractExperts Sound Alarm: Popular Hair Loss Drug Linked to Suicide
A popular hair-loss drug may have dangerous mental health effects long dismissed by authorities. Scientists now demand urgent regulatory reform. A new review by a public health researcher at the Hebrew University of Jerusalem uncovers that finasteride, a widely used medication for hair loss, has been associated with depression and suicide for more than twenty [...]
Hair loss treatment used by millions linked to suicide risk: ‘Evidence is no longer anecdotal’
New research suggests that patients using a popular drug for male pattern baldness face a significantly higher risk of mood disorders and suicidal thoughts compared to those who don’t.
Coverage Details
Bias Distribution
- 62% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
